ACM
Atika Capital Management Portfolio holdings
AUM
$957M
1-Year Return
61.67%
This Quarter Return
+16.19%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$244M
AUM Growth
+$19.4M
(+8.7%)
Cap. Flow
+$5.63M
Cap. Flow
% of AUM
2.31%
Top 10 Holdings %
Top 10 Hldgs %
33.21%
Holding
91
New
19
Increased
19
Reduced
27
Closed
16
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$4.54M |
| 2 |
Intuitive Surgical
ISRG
|
$4.36M |
| 3 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$4.3M |
| 4 |
Albemarle
ALB
|
$3.95M |
| 5 |
Baidu
BIDU
|
$3.72M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$4.67M |
| 2 |
Autodesk
ADSK
|
$4.27M |
| 3 |
MDCO
Medicines Co
MDCO
|
$4.15M |
| 4 |
Zillow
Z
|
$3.6M |
| 5 |
Liberty Media Series C
FWONK
|
$3.01M |
Sector Composition
| 1 | Healthcare | 39.23% |
| 2 | Communication Services | 18.81% |
| 3 | Technology | 18.65% |
| 4 | Consumer Discretionary | 7.28% |
| 5 | Materials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Centene
CNC
$14B
| $2.17M | 0.62% |
44,926
-15,074
| -25% | -$729K |
|
52
Jazz Pharmaceuticals
JAZZ
$7.85B
| $2.12M | 0.61% |
14,500
-4,000
| -22% | -$585K |
|
|
ONCE
53
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.05M | 0.59% |
+23,000
| New | +$2.05M |
|
54
Roku
ROKU
$14.4B
| $1.91M | 0.55% |
+72,000
| New | +$1.91M |
|
|
55
Liberty Media Series C
FWONK
$25B
| $1.91M | 0.55% |
51,714
-81,709
| -61% | -$3.01M |
|
|
IMMU
56
DELISTED
Immunomedics Inc
IMMU
| $1.89M | 0.54% |
+135,000
| New | +$1.89M |
|
57
Heron Therapeutics
HRTX
$196M
| $1.45M | 0.42% |
90,000
+12,000
| +15% | +$194K |
|
|
ZGNX
58
DELISTED
Zogenix, Inc.
ZGNX
| $1.4M | 0.4% |
40,000
+11,000
| +38% | +$386K |
|
59
Exelixis
EXEL
$10B
| $1.21M | 0.35% |
50,000
-15,000
| -23% | -$363K |
|
|
BLUE
60
DELISTED
bluebird bio
BLUE
| $1.1M | 0.32% |
618
-1,312
| -68% | -$2.33M |
|
|
SLCA
61
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.09M | 0.31% |
35,000
-32,000
| -48% | -$994K |
|
62
Alkermes
ALKS
$4.78B
| $1.07M | 0.31% |
21,000
| – | – |
|
63
Regenxbio
RGNX
$470M
| $988K | 0.28% |
+30,000
| New | +$988K |
|
|
DBVT
64
DBV Technologies
DBVT
$254M
| $848K | 0.24% |
+2,000
| New | +$848K |
|
|
MRNS
65
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $758K | 0.22% |
+32,250
| New | +$758K |
|
66
Esperion Therapeutics
ESPR
$488M
| $686K | 0.2% |
+13,700
| New | +$686K |
|
|
REED
67
DELISTED
Reeds, Inc. Common Stock
REED
| $62K | 0.02% |
+563
| New | +$62K |
|
68
AbbVie
ABBV
$376B
| – | – |
0
| – | – |
|
69
Appian
APPN
$2.23B
| – | – |
-120,000
| Closed | -$2.18M |
|
70
Bausch Health
BHC
$2.65B
| – | – |
0
| – | – |
|
71
Bristol-Myers Squibb
BMY
$95.7B
| – | – |
0
| – | – |
|
72
EPAM Systems
EPAM
$9.41B
| – | – |
-19,000
| Closed | -$1.6M |
|
73
Glaukos
GKOS
$5.23B
| – | – |
-18,000
| Closed | -$746K |
|
74
HCA Healthcare
HCA
$96.7B
| – | – |
0
| – | – |
|
75
Ironwood Pharmaceuticals
IRWD
$177M
| – | – |
-107,460
| Closed | -$1.7M |
|